Erythropoietin-induced neuroprotection requires cystine glutamate exchanger activity

Brain Research

Volumn 1321, Issue , 2010, Pages 88-95

  Sims, Brian ^a,b   Clarke, Melinda ^a   Njah, Wilfred ^a   Hopkins, E'lana Shuford ^a   Sontheimer, Harald ^a,c  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c University of Alabama at Birmingham   (United States)

Author keywords

Cystine glutamate exchanger; Erythropoietin; Neuroprotection; xCT

Indexed keywords

CYSTINE; ERYTHROPOIETIN; GLUTAMIC ACID; GLUTATHIONE; KAINIC ACID; SMALL INTERFERING RNA;

AMINO ACID TRANSPORT; ANIMAL CELL; ARTICLE; CELL DEATH; CELL DIFFERENTIATION; CELL VIABILITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG INHIBITION; EXCITOTOXICITY; HUMAN; HUMAN CELL; MOUSE; NEURAL STEM CELL; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

AMINO ACID TRANSPORT SYSTEM Y+; ANIMALS; BLOTTING, WESTERN; CELLS, CULTURED; ERYTHROPOIETIN; GLUTATHIONE; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; NEURONS; NEUROPROTECTIVE AGENTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; STEM CELLS;

EID: 77549083364     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2010.01.040     Document Type: Article

References (34)

1. Back S.A., et al. Maturation-dependent vulnerability of oligodendrocytes to oxidative stress-induced death caused by glutathione depletion. J. Neurosci. 18 (1998) 6241-6253
2. Buemi M., et al. Erythropoietin and the brain: from neurodevelopment to neuroprotection. Clin. Sci. (Lond). 103 (2002) 275-282
3. Calapai G., et al. Erythropoietin protects against brain ischemic injury by inhibition of nitric oxide formation. Eur. J. Pharmacol. 401 (2000) 349-356
4. Chong Z.Z., et al. Erythropoietin prevents early and late neuronal demise through modulation of Akt1 and induction of caspase 1, 3, and 8. J. Neurosci. Res. 71 (2003) 659-669
5. Chong Z.Z., et al. Vascular injury during elevated glucose can be mitigated by erythropoietin and Wnt signaling. Curr. Neurovasc. Res. 4 (2007) 194-204
6. Chung W.J., et al. Inhibition of cystine uptake disrupts the growth of primary brain tumors. J. Neurosci. 25 (2005) 7101-7110
7. d'Uscio L.V., et al. Essential role of endothelial nitric oxide synthase in vascular effects of erythropoietin. Hypertension 49 (2007) 1142-1148
8. Digicaylioglu M., and Lipton S.A. Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades. Nature 412 (2001) 641-647
9. Fenjves E.S., et al. Adenoviral gene transfer of erythropoietin confers cytoprotection to isolated pancreatic islets. Transplantation 77 (2004) 13-18
10. Genc S., et al. Erythropoietin restores glutathione peroxidase activity in 1-methyl-4-phenyl-1, 2, 5, 6-tetrahydropyridine-induced neurotoxicity in C57BL mice and stimulates murine astroglial glutathione peroxidase production in vitro. Neurosci. Lett. 321 (2002) 73-76
11. Ghezzi P., and Brines M. Erythropoietin as an antiapoptotic, tissue-protective cytokine. Cell Death Differ. 11 Suppl 1 (2004) S37-S44
12. Guneli E., et al. Erythropoietin protects the intestine against ischemia/reperfusion injury in rats. Mol. Med. 13 (2007) 509-517
13. Hasselblatt M., et al. The brain erythropoietin system and its potential for therapeutic exploitation in brain disease. J. Neurosurg. Anesthesiol. 18 (2006) 132-138
14. Joyeux-Faure M. Cellular protection by erythropoietin: new therapeutic implications?. J. Pharmacol. Exp. Ther. 323 (2007) 759-762
15. Katavetin P., et al. Antioxidative effects of erythropoietin. Kidney Int. Suppl. (2007) S10-S15
16. Krantz S.B. Erythropoietin and the anaemia of chronic disease. Nephrol. Dial. Transplant. 10 Suppl 2 (1995) 10-17
17. Latini R., et al. Do non-hemopoietic effects of erythropoietin play a beneficial role in heart failure?. Heart Fail. Rev. 13 (2008) 415-423
18. Liu J., et al. Neuroprotection by hypoxic preconditioning involves oxidative stress-mediated expression of hypoxia-inducible factor and erythropoietin. Stroke 36 (2005) 1264-1269
19. Ribatti D., et al. Erythropoietin/erythropoietin receptor system is involved in angiogenesis in human neuroblastoma. Histopathology 50 (2007) 636-641
20. Rosin C., et al. Excitatory amino acid induced oligodendrocyte cell death in vitro: receptor-dependent and -independent mechanisms. J. Neurochem. 90 (2004) 1173-1185
21. Ruscher K., et al. Erythropoietin is a paracrine mediator of ischemic tolerance in the brain: evidence from an in vitro model. J. Neurosci. 22 (2002) 10291-10301
22. Sartelet H., et al. Expression of erythropoietin and its receptor in neuroblastomas. Cancer 110 (2007) 1096-1106
23. Sato H., et al. Molecular cloning and expression of human xCT, the light chain of amino acid transport system Xc. Antioxid. Redox Signal. 2 (2000) 665-671
24. Sato H., et al. Distribution of cystine/glutamate exchange transporter, system X(c)-, in the mouse brain. J. Neurosci. 22 (2002) 8028-8033
25. Seko Y., et al. Vascular endothelial growth factor (VEGF) activates Raf-1, mitogen-activated protein (MAP) kinases, and S6 kinase (p90rsk) in cultured rat cardiac myocytes. J. Cell. Physiol. 175 (1998) 239-246
26. Shih A.Y., et al. Coordinate regulation of glutathione biosynthesis and release by Nrf2-expressing glia potently protects neurons from oxidative stress. J. Neurosci. 23 (2003) 3394-3406
27. Shih A.Y., et al. Cystine/glutamate exchange modulates glutathione supply for neuroprotection from oxidative stress and cell proliferation. J. Neurosci. 26 (2006) 10514-10523
28. Sola A., et al. Erythropoietin after focal cerebral ischemia activates the Janus kinase-signal transducer and activator of transcription signaling pathway and improves brain injury in postnatal day 7 rats. Pediatr. Res. 57 (2005) 481-487
29. Szczepanski M., et al. Erythropoietin prevents oxidative stress and lipid peroxidation process in human umbilical vein endothelial cells induced by tumor necrosis factor alpha. Pol. Merkur. Lekarski. 21 (2006) 534-539
30. Uppenkamp M., et al. Thrombopoietin serum concentration in patients with reactive and myeloproliferative thrombocytosis. Ann. Hematol. 77 (1998) 217-223
31. Wells R.G., et al. The 4F2 antigen heavy chain induces uptake of neutral and dibasic amino acids in Xenopus oocytes. J. Biol. Chem. 267 (1992) 15285-15288
32. Wu Y., et al. Erythropoietin prevents PC12 cells from 1-methyl-4-phenylpyridinium ion-induced apoptosis via the Akt/GSK-3beta/caspase-3 mediated signaling pathway. Apoptosis 12 (2007) 1365-1375
33. Yamamoto M., et al. Effect of erythropoietin on nitric oxide production in the rat hippocampus using in vivo brain microdialysis. Neuroscience 128 (2004) 163-168
34. Yu X., et al. Erythropoietin receptor signalling is required for normal brain development. Development 129 (2002) 505-516